CrossrefInfokarte
Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey
European Journal of Cancer · 2026-11 · 248 · 117061
DOI: 10.1016/j.ejca.2026.117061 ↗Abstract
Kein Abstract verfügbar.
EUVIMED